2017
DOI: 10.1016/j.bpobgyn.2016.10.012
|View full text |Cite
|
Sign up to set email alerts
|

Update in the genetics of thalassemia: What clinicians need to know

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
71
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 83 publications
(73 citation statements)
references
References 48 publications
1
71
0
1
Order By: Relevance
“…Our findings, and those from other studies (Hu et al , ; Clark et al , ), have proved that combinations of MLPA, array comparative genomic hybridization (array CGH) and NGS assays are very useful for identifying the known or unknown rearrangements in α‐ or β‐globin gene clusters. This duplication not only widens the spectrum of CNVs in globin genes but it is also the first report of a de novo large duplication, although some de novo point mutations have previously been found at this locus (Shang & Xu, ).…”
Section: Resultsmentioning
confidence: 80%
See 1 more Smart Citation
“…Our findings, and those from other studies (Hu et al , ; Clark et al , ), have proved that combinations of MLPA, array comparative genomic hybridization (array CGH) and NGS assays are very useful for identifying the known or unknown rearrangements in α‐ or β‐globin gene clusters. This duplication not only widens the spectrum of CNVs in globin genes but it is also the first report of a de novo large duplication, although some de novo point mutations have previously been found at this locus (Shang & Xu, ).…”
Section: Resultsmentioning
confidence: 80%
“…In the clinic, researchers and clinicians sometimes detect thalassaemia patients whose inheritance mode contradicts Mendelian laws. Many such patients can be explained by two mechanisms: (i) β‐thalassaemia carriers can co‐inherit a duplication of α‐globin ( HBA ) genes that results in thalassaemia intermedia (TI), or (ii) A de novo point mutation or large deletions combined with another mutation, inherited from the parents, which lead to thalassaemia (Hu et al , ; Shang & Xu, ). However, the origin of the de novo mutation is rarely analysed and there are still a small number of cases that are difficult to explain.…”
mentioning
confidence: 99%
“…The 5′ breakpoint of these two deletions was very similar to this 223 kb deletion, both with a similar 5′ breakpoint to this case (Figure A). Three mechanisms may contribute to this different HbF level: (a) the 3′ breakpoints of the above two deletions were different from the present case; (b) the expression of HbF is regulated by many genetic modifiers such as XmnI polymorphism, KLF1, BCL11A, HBS1L, and MYB . The NGS data of our cases showed that they were all negative for mutations in these factors, while this information was absent for the carriers of the above two deletions; and (c) the 5′ breakpoint of the 223 kb deletion was not completely consistent in the above two deletions.…”
Section: Discussionmentioning
confidence: 99%
“…Most cases with β‐thalassemia are caused by point mutations or small deletions with several nucleotides lost in the beta‐globin gene . But deletions longer than 1 kb, which can be classified as large deletion, were also reported intermittently. Large deletions of the beta‐globin gene cluster reported previously have mostly been classified genetically into εγδβ 0 ‐thalassemia, ( G γ A γδβ) 0 ‐thalassemia, G γ( A γδβ) 0 ‐thalassemia, δβ 0 ‐thalassemia, and β 0 ‐thalassemia according to the gene(s) involved .…”
Section: Introductionmentioning
confidence: 99%
“…Mutations in the alpha or beta globin genes can cause abnormal variants of HbA (hemoglobinopathies, such as sickle cell disease) or a decrease in production of one of the respective globin chain types (thalassemia) [17]. Alpha thalassemia is usually caused by a deletion of one or more of the alpha globin genes, leading to a decrease in alpha chain production and a relative excess of beta chains.…”
Section: Genetics Of Alpha and Beta Thalassemiamentioning
confidence: 99%